Iambic Provides Business Updates and Third Quarter 2026 Financial Results

Launched Enchant® v3, a 41-billion-parameter transformer model for drug discovery and development, to drive decisions across our internal and partnership activitiesSigned AI discovery collaborations with Bayer and AbbVie; eight total partnerships signed since 2024Achieved a program milestone in Takeda collaboration, triggering a $1.0 million payment; AI-driven drug discovery collaboration was announced only nine months ago in February 2026Presented updated IAM1363 (HER2) data from ongoing Phase

Nov 16, 2026 - 16:00
 0  0
Iambic Provides Business Updates and Third Quarter 2026 Financial Results
Launched Enchant® v3, a 41-billion-parameter transformer model for drug discovery and development, to drive decisions across our internal and partnership activitiesSigned AI discovery collaborations with Bayer and AbbVie; eight total partnerships signed since 2024Achieved a program milestone in Takeda collaboration, triggering a $1.0 million payment; AI-driven drug discovery collaboration was announced only nine months ago in February 2026Presented updated IAM1363 (HER2) data from ongoing Phase

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow